Events in the Series
Advancing Novel Targets, Defining & Securing Translational Efficacy & Overcoming Clinical Challenges to Develop More Effective & Disease-Modifying IPF Drugs
Returning 2023
Deepen Scientific Understanding of Inflammatory & Fibrotic ILDs, Investigate Biomarkers to Stratify Trial Populations and Identify Endpoints Which are Likely to Predict Clinical Success in Your Next Clinical Trial
Returning in April 2023
Harness Advances in GLP-1 Receptor Agonists to Drive Drug-Based Management of Obesity
Accelerate Towards Validation of Non-Invasive Biomarkers to Establish Efficacy
Combination Therapy in Obesity & NASH & Holistic Approaches to Metabolic Syndrome
